Literature DB >> 14646203

Reduction of antigenicity of Cry j I, major allergen of Japanese cedar pollen, by the attachment of polysaccharides.

Masakatsu Usui1, Akira Saito, Naohiro Taniguchi, Noriaki Nishijima, Hiroyuki Azakami, Akio Kato.   

Abstract

An attempt was made to mask the allergenic structure of a major allergen protein, Cry j I (CJI), in Japanese cedar pollen using the Maillard-type polysaccharide conjugation. The SDS-PAGE pattern of the CJI-galactomannan conjugate prepared by the Maillard reaction showed broad bands widely distributed from 50 kDa to more than 100 kDa, suggesting the attachment of galactomannan. The competitive enzyme-linked immunosorbent assay showed that the IgE antibody in the sera of cedar pollen-sensitive patients reacted strongly with CJI, while it did not react with the CJI-galactomannan conjugate. This result suggests that the antigenicity of CJI is greatly reduced by the conjugation with galactomannan.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14646203     DOI: 10.1271/bbb.67.2425

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  4 in total

Review 1.  Next generation immunotherapy for tree pollen allergies.

Authors:  Yan Su; Eliezer Romeu-Bonilla; Teri Heiland
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

2.  Safety and efficacy of short-term oral immunotherapy with Cry j 1-galactomannan conjugate for Japanese cedar pollinosis: a randomized controlled trial.

Authors:  Daisuke Murakami; Motohiro Sawatsubashi; Hirofumi Omori; Akira Saito; Akio Kato; Shizuo Komune; Takashi Nakagawa
Journal:  Sci Rep       Date:  2017-04-11       Impact factor: 4.379

3.  Reduction of the number of major representative allergens: from clinical testing to 3-dimensional structures.

Authors:  Ying He; Xueting Liu; Yuyi Huang; Zehong Zou; Huifang Chen; He Lai; Lida Zhang; Qiurong Wu; Junyan Zhang; Shan Wang; Jianguo Zhang; Ailin Tao; Baoqing Sun
Journal:  Mediators Inflamm       Date:  2014-03-23       Impact factor: 4.711

4.  Transcutaneous Delivery of Immunomodulating Pollen Extract-Galactomannan Conjugate by Solid-in-Oil Nanodispersions for Pollinosis Immunotherapy.

Authors:  Qingliang Kong; Kouki Higasijima; Rie Wakabayashi; Yoshiro Tahara; Momoko Kitaoka; Hiroki Obayashi; Yanting Hou; Noriho Kamiya; Masahiro Goto
Journal:  Pharmaceutics       Date:  2019-10-30       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.